related_tweet: @garettjones @tiredofthecon @mrwbond @tylercowen @slatestarcodex again, not going to retrospectively fault pfizer and biontech for making a business decision that was rational *in expectation*.
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  if the 32-case analysis was adhered to, the vaccine would have probably been approved in late november, yes. but we only know this in retrospect.